# A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of Life

> **NCT00222105** · PHASE2 · COMPLETED · sponsor: **University of Kansas Medical Center** · enrollment: 25 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Doxil
- **DRUG:** Thalidomide
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT00222105
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2009-04
- **Final completion:** 2009-07
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2017-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00222105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00222105, "A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of Life". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00222105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*